BENEKLİ, M. Et Al. 2021. Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.27, no.7 , 1623-1630.

BENEKLİ, M., Gumus, M., ÖZKAN, M., Dane, F., ELKIRAN, E. T., ÇİÇİN, İ., ... Sevinc, A.(2021). Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.27, no.7, 1623-1630.

BENEKLİ, MUSTAFA Et Al. "Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.27, no.7, 1623-1630, 2021

BENEKLİ, MUSTAFA Et Al. "Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.27, no.7, pp.1623-1630, 2021

BENEKLİ, M. Et Al. (2021) . "Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.27, no.7, pp.1623-1630.

@article{article, author={MUSTAFA BENEKLİ Et Al. }, title={Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2021, pages={1623-1630} }